glp-1 drugs for obesity What's New in Treatment? Oral GLP-1 Medication Helps Patients

Rare sugar syrup containing D-allulose but not high-fructose corn syrup maintains glucose homeostasis and hepatic gene expression in wistar rats

Serious allergic reactions can happen with Saxenda

(5.7) Acute Gallbladder Disease: If cholelithiasis or cholecystitis are suspected, gallbladder studies are indicated

Discontinuation rates due to adverse events were higher in the active treatment groups compared with placebo, particularly at higher doses, though the overall discontinuation rate remained relatively modest

Wegovy (semaglutide), which was approved in 2021 (it was previously available for diabetes as Ozempic and in an oral form for diabetes as Rybelsus)